Awarded Grants for CISNET I and CISNET II

CISNET Affiliate Program

CISNET encourages the participation of modelers who are not funded through the CISNET mechanism. Currently CISNET has eight affiliate members in cancer site groups: three in breast, three in colorectal, and two in lung. Investigators working on population modeling of cancer trends who wish to be associated with the CISNET group may apply for affiliate status. Affiliates attend meetings, share results, and participate in joint collaborations when applicable.


Breast Cancer Modeling Grants

Principal Investigator
and Institution
Title
CISNET I
(R1 or R2*)
CISNET II
Donald A. Berry, Ph.D.
M. D. Anderson Cancer Center
Cancer Intervention and Surveillance Modeling Network (CISNET) Funded R1 Affiliate
Dennis G. Fryback, Ph.D.
University of Wisconsin - Madison
Simulating Breast Cancer in Wisconsin Funded R1 -
J. Dik F. Habbema, Ph.D.
Erasmus MC, University Medical Center Rotterdam
Surveillance of Breast Cancer Trends by MISCAN Funded R1 -
Jeanne Mandelblatt, M.D., M.P.H.
Georgetown University Medical Center1
CISNET: The "Spectrum" of Breast Cancer Disparities Funded R1 Funded
Sylvia K. Plevritis, Ph.D.
Stanford University
Breast Cancer Trend Analysis Using Stochastic Simulation Funded R1 Funded
Andrei Y. Yakovlev, Ph.D.
University of Rochester
Mechanistic Modeling of Breast Cancer Surveillance Funded R1 -
Sandra Lee, D.Sc. (current PI)
Marvin Zelen, Ph.D. (previous PI)
Dana-Farber Cancer Institute
Breast Cancer: Role of Early Detection, Treatment and Prevention Funded R1 Funded
Leslie Gaudette, M.Sc.
Health Canada
  - Affiliate
Oguzhan Alagoz, Ph.D. and
Amy Trentham-Dietz, Ph.D.
University of Wisconsin - Madison
Using The UWBCS To Assess Racial Disparities In Breast Cancer Incidence & Survival - Affiliate
Natasha Stout, Ph.D.
Harvard Medical School/Harvard Pilgrim Health Care
  - Affiliate

Colorectal Cancer Modeling Grants

Principal Investigator
and Institution
Title
(click for abstract)
CISNET I
(R1 or R2*)
CISNET II
Karen M. Kuntz, D.Sc.
University of Minnesota School of Public Health3
A Population-Based Policy Model for Colorectal Cancer Funded R1 Funded
Carolyn M. Rutter, Ph.D.
Group Health Research Institute
Colorectal Cancer Screening: Evaluating Trends and Outcomes Funded R2 Funded
Ann G. Zauber, Ph.D.
Sloan Kettering Institute for Cancer Research1
Colorectal Cancer Surveillance with MISCAN Modeling Funded R2 Funded
Georg Luebeck, Ph.D.
Fred Hutchinson Cancer Research Center
Modeling Colon Cancer, Intervention and Prevention - Affiliate
Scott D. Ramsey, Ph.D.
Fred Hutchinson Cancer Research Center1
A Genetic Screening Policy Model for Colorectal Cancer - Affiliate
David Vanness, Ph.D.
University of Wisconsin Medical School
Cost-Effectiveness Modeling of ACRIN 6664 (National Colongraphy Trial) - Affiliate

Colorectal Cancer Coordinating Center Grant

Principal Investigator
and Institution
Title
(click for abstract)
CISNET I
(R1 or R2*)
CISNET II
Ann G. Zauber, Ph.D.
Sloan Kettering Institute for Cancer Research1
Coordinating Center for Colorectal Microsimulation - Funded

Lung Cancer Modeling Grants

Principal Investigator
and Institution
Title
(click for abstract)
CISNET I
(R1 or R2*)
CISNET II
Harry de Koning, M.D., Ph.D. (current PI)
Erasmus MC, University Medical Center Rotterdam
Rob Boer, Ph.D. (previous PI)
RAND Corporation
Cancer Intervention and Surveillance Modeling Network Funded R2 Funded
Theodore R. Holford, Ph.D.
Yale University
Modeling Interventions for Lung Cancer Mortality Funded R2 Funded
Marek Kimmel, Ph.D.
Rice University2
Modeling Lung Cancer: Risks, Progression, and Screening Funded R2 Funded
David T. Levy, Ph.D.
Pacific Institute for Research and Evaluation
A Simulation of Tobacco Policy, Smoking and Lung Cancer Funded R2 Funded
Suresh H. Moolgavkar, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
Lung Cancer in the US: Pathogenesis, Trends, Prevention Funded R2 Funded
G. Scott Gazelle, M.D., M.P.H., Ph.D.
Massachusetts General Hospital
A Lung Cancer Policy Model - Affiliate
Sylvia K. Plevritis, Ph.D.
Stanford University
Cost-Effectiveness Analysis of Lung Cancer Screening - Affiliate

Prostate Cancer Modeling Grants

Principal Investigator
and Institution
Title
(click for abstract)
CISNET I
(R1 or R2*)
CISNET II
Harry de Koning, M.D., Ph.D.
Erasmus MC, University Medical Center Rotterdam
A Trial-based MISCAN Model for Prostate Cancer - Funded
Ruth Etzioni, Ph.D.
Fred Hutchinson Cancer Research Center
PSA Screening and U.S. Prostate Cancer Trends Funded R1 Funded
Alexander Tsodikov, Ph.D.
University of Michigan
Survival Effects of Prostate Cancer Surveillance Funded R2 Funded

* CISNET I was funded in two rounds: The first round (R1) began in 2000, followed by the second round (R2) in 2002.
1 Collaboration with Erasmus MC, University Medical Center Rotterdam (MISCAN model).
2 Collaboration with M. D. Anderson Cancer Center and Weil Cornell Medical Center.
3 Collaboration with Massachusetts General Hospital.

Location of the CISNET II Grantees and Affiliates

CISNET and the Challenge of Delivery